Skip to main content
. 2013 Jun 20;115(4):446–455. doi: 10.1152/japplphysiol.00446.2013

Table 2.

Baseline (resting) hemodynamics under each condition

Young
Older
FBF, ml/min FVC, ml/min MAP, mmHg Heart rate, beats/min FBF, ml/min FVC, ml/min MAP, mmHg Heart rate, beats/min
Control
    10% MVC 66 ± 10 67 ± 11 98 ± 2 61 ± 2 72 ± 8 68 ± 8 105 ± 2* 63 ± 2
    20% MVC 66 ± 10 68 ± 11 97 ± 2 61 ± 2 72 ± 6 67 ± 6 104 ± 3* 63 ± 2
    40% MVC 66 ± 8 66 ± 8 98 ± 2 61 ± 2 67 ± 6 63 ± 6 104 ± 2* 63 ± 2
l-NMMA
    10% MVC 47 ± 8 45 ± 8 103 ± 3 59 ± 2 44 ± 4 40 ± 4 113 ± 2* 61 ± 2
    20% MVC 41 ± 7 41 ± 7 103 ± 3 60 ± 2 42 ± 6 37 ± 5 113 ± 1* 61 ± 2
    40% MVC 45 ± 8 44 ± 8 103 ± 3 60 ± 2 43 ± 5 38 ± 4 113 ± 2* 62 ± 2

Values are means ± SE. l-NMMA, NG-monomethyl-l-arginine; FBF, forearm blood flow; FVC, forearm vascular conductance.

*

P < 0.05 vs. young.

P < 0.05 vs. control at respective MVC.

HHS Vulnerability Disclosure